ArticleInternational journal of general medicine2026
Clinical Characteristics and Independent Risk Factors of Primary Gastrointestinal Lymphoma Complicated with Gastrointestinal Complications.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical features of primary intestinal follicular lymphoma: A single-center retrospective study.The Journal of international medical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to investigate the clinical characteristics and risk factors of primary gastrointestinal lymphoma (PGIL) in patients with gastrointestinal complications (GICs). Methods: A retrospective analysis was conducted on the clinical data of 148 patients with PGIL admitted to Yichang Central People's Hospital from January 2019 to August 2025. Univariable and multivariable logistic regression models were utilized to identify independent risk factors for GICs. Results: Patients with PGIL exhibited a high incidence (58.1%) of GICs, primarily bleeding, obstruction, and perforation. Bleeding predominantly involves gastric ulcerative lesions, whereas obstruction and perforation frequently affect the small intestine, with obstruction typically presenting endoscopically as protruding lesions. Compared to the non-GIC cohort, patients with GICs showed a significantly higher proportion of diffuse large B-cell lymphoma (DLBCL), poorer performance status (ECOG ≥ 2), and advanced tumor invasiveness. Furthermore, the GICs group demonstrated marked metabolic depletion, elevated systemic inflammation, significant bowel wall thickening, and lymphadenopathy. Crucially, multivariable analysis identified four independent risk factors for developing GICs: history of hypertension (odds ratio [OR] =3.724, CI: 1.149-12.074), primary intestinal site (OR=3.551, 95% CI: 1.240-10.170), deep lesion infiltration into the muscularis or serosa (OR=3.615, 95% CI: 1.132-11.546), and anemia (OR=4.288, 1.457-12.615). Conclusion: The high incidence of GICs in patients with PGIL is multifactorial. Early risk stratification and tailored interventions are crucial for patients presenting with hypertension, anemia, intestinal involvement, or deep tumor infiltration at the initial diagnosis to optimize therapeutic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.